FT : Hedge funds loom large in oil price moves

Hedge funds loom large in oil price moves
Forget the interplay between supply and demand. When it comes to oil prices, hedge funds and speculators are exerting an uncommonly large influence, say many in one of the world’s most important markets.
Oil traders have watched future prices rally to their highest level this year, within touching distance of $70 a barrel, even as the price of physical cargoes flounders under the weight of a massive oversupply.

In an attempt to explain the conundrum, experienced traders are pointing at the influence of multibillion-dollar macro funds. While much of the increase in speculative demand has been driven by a perceived improvement in oil fundamentals, as US drillers have curtailed activity, other factors have been at work.
Traders say funds have bought oil futures not just as a bet on an eventual oil price recovery, but as a hedge against a weaker US dollar, rising government bond yields and shifting inflation expectations, which have roiled the bigger part of their portfolios.
“Ultimately, the dominant force in the crude market today is macro funds, with talk of diversification and inflation back on the agenda,” says Energy Aspects, a London-based consultant.
“Some of these multibillion-dollar macro funds may only be putting 1 per cent of their portfolio in oil, but that is enough to dwarf far smaller fundamentally focused funds at times.”
After the European Central Bank announced the launch of quantitative easing in January, a popular trade was to sell euros and buy the German Bund and US dollar.

But German 10-year Bund yields have risen towards 0.70 per cent after threatening to turn negative last month. That has led some funds to start unwinding the trade or look at additional hedges for large positions they might struggle to exit quickly.
“If you fear a Bund price fall driven by inflation, then buying Brent provides some protection,” says David Hufton, chief executive of PVM, an oil broker. The correlation between Brent and Bund yields is more than 90 per cent, he adds.
More broadly, buying oil when the dollar weakens also acts as an offsetting position for some investors, given most commodities are priced in the world’s reserve currency.
The dollar was a contributing factor to oil’s crash between June and January as it rose 16 per cent against a basket of other currencies. However, the 60 per cent decline in crude from about $115 to $45 a barrel over the same period illustrates how crude was largely trading on its own fundamentals, as the US shale boom contributed to oversupply.

But the scale of futures based trading in the oil market is immense, and an important driver of prices.
During the past decade there has been a surge in the volume of crude contracts traded on ICE and Nymex, the main commodity exchanges. Daily average turnover has increased from 350,000 futures contracts in 2005, when electronic trading started to dominate, to 1.5m — or 16 times the world’s global daily oil demand — according to calculations by the Financial Times.
Exchange and regulatory data show that funds hold net positions in futures and options markets in London and New York equivalent to about 510m barrels of crude. That is equal to more than five days of global demand, or the combined monthly output of Saudi Arabia, Iraq and Iran, the biggest producers in Opec.

Some investors are warning that fund buying could dry up or reverse, putting pressure on prices. When oil was $10 lower “there was a lot of hedge fund interest in buying oil as it looked oversold”, says one manager of a fund-of-funds in London. “But there’s less interest now after the rally, as it has started to look a little too extended.”
A third of the most active US oil futures contract is controlled by exchange traded funds, popular with retail investors and hedge funds.
Hedge fund short positions, or bets that the price will fall, increased during the oil price rout, though in West Texas Intermediate, the US benchmark, they peaked in March at about 200m barrels, almost two months after the price had troughed.

Some market participants see the closure of more than half of those short positions since then as helping accelerate oil’s recovery. WTI was just below $60 on Friday.
“Futurisation of oil has been as dramatic in its impact as the arrival of horizontal drilling and fracking,” says Mr Hufton. “Fracking transformed oil supply dynamics; futurisation has transformed the factors driving oil prices.”
Goldman Sachs, one of the most influential banks in commodity markets, is warning that the rally may have gone too far. While its analysts see stronger demand from Asia and other fundamental factors as supportive of the price, they wrote in a note this week that the large hedge fund long position in oil could trigger a sell-off if the funds take profits.
“While it is possible that markets have become more forward looking and are already looking beyond the near-term fundamentals, just like they did last fall, we ultimately don’t share this forward view of sharply improving fundamentals, even in 2016,” the bank said.

>>> ANN Inc Agrees To be acquired by Ascena Retail Group, Inc. for $47/shr in ca

Agrees To be acquired by Ascena Retail Group, Inc. for $47/shr in cash and stock (21% premium) total deal valued around $2.0B

Ascena retail group have entered into a definitive merger agreement under which ascena will acquire ANN INC. for a combination of cash and stock in an accretive transaction. Upon closing, ANN INC. stockholders will receive $37.34 in cash and 0.68 of a share of ascena common stock in exchange for each share of ANN common stock. Based upon the closing price of ascena stock on May 15, 2015, this implies a price per share of $47.00, a 21.4% premium over the closing price of ANN shares on Friday, May 15, 2015. At closing, ANN stockholders will own approximately 16% of ascena. 

The transaction, which has been unanimously approved by the Boards of Directors of both companies, is expected to close in the second half of 2015, subject to customary closing conditions, including, among other things: the expiration or early termination of the waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 and approval of the merger by the holders of a majority of the outstanding shares of ANN. The transaction does not require approval by ascena stockholders.

David Jaffe, ascena's President and Chief Executive Officer, commented: "This powerful transaction joins two strong and highly complementary organizations and management teams and dramatically reinforces our leadership position in women's specialty apparel retailing. We are excited to further leverage our uniquely capable operating platform and exceptional combined talent to drive immediate, significant and ongoing value for our stockholders. With the addition of the Ann Taylor and LOFT brands, ascena will become one of North America's largest and most diversified specialty apparel retailers, with a tremendous set of opportunities to continue to expand its leadership position in the women's apparel market."ascena has identified $150 million in annualized run rate synergies in the combination that it expects to generate over a three-year period. The transaction aligns seamlessly with ascena's platform strategy and shared services model, designed to enable an effective, rapid and comprehensive back office integration process. Synergies include sourcing and procurement, distribution, logistics and other efficiencies. Excluding transaction and integration expenses, the acquisition is expected to be significantly accretive to EPS in the first year post closing, accelerating to greater than 20% accretion to EPS thereafter. Additionally, ascena expects the combination to generate significant cash flow while both maintaining appropriate levels of capital expenditures and enabling rapid deleveraging.Ronald Hovsepian, Non-Executive Chairman of ANN INC.'s Board of Directors, said, "Based on our Board's thorough and wide-ranging review process, we are confident that this agreement with ascena is in the best interests of ANN INC.'s stockholders. Our stockholders will receive approximately 80% of the purchase price in cash, providing immediate and certain value, and also have the opportunity to participate in the upside of the combined company as a result of the stock portion of the purchase price. We are delighted with this outcome for ANN INC.'s stockholders."Kay Krill, President and Chief Executive Officer of ANN INC., added, "I am very proud of all we have accomplished and confident that combining with ascena is the right next step for ANN INC. 

The transaction will make us part of a larger organization with a diversified portfolio of brands focused on the women's apparel market, a strong operating platform and a powerful financial base. I have tremendous respect and admiration for ascena's CEO David Jaffe, and our management team and I look forward to working alongside him and other senior members of the ascena team. As a member of the ascena family, ANN will be poised to further enhance and grow our business as we continue to take steps to better strategically and operationally position our brands for the dynamics that are redefining the landscape of the women's specialty retailing industry. At the same time, we look forward to continuing to meet our clients' wardrobing needs by delivering great product and a seamless brand experience across our multiple touchpoints."

Transaction Details

Under the terms of the transaction, upon closing, ANN INC. stockholders will receive $37.34 in cash and 0.68 of a share of ascena common stock for each share of ANN INC. common stock, implying a price per share of $47.00 based on the closing price of ascena stock on May 15, 2015. The transaction gives ANN INC. an enterprise value of approximately $2.0 billion.ascena intends to finance the acquisition through bank debt. Goldman, Sachs & Co. and Guggenheim Securities have arranged committed financing for the transaction. Guggenheim Securities and Goldman, Sachs & Co. acted as financial advisors to ascena. Proskauer Rose LLP acted as legal counsel to ascena in connection with the transaction. J.P. Morgan Securities LLC acted as the exclusive financial advisor to ANN in connection with the strategic review process and the transaction. Wachtell, Lipton, Rosen & Katz acted as legal counsel to ANN INC. in connection with the strategic review process and the transaction

>>> US Early premarket Gappers


Early premarket gappers


Gapping up: AMCO +18.1%, XGTI +9.6%, PSTI +9.3%, VRS +6.9%, GURE +6.9%, ALTR +6.5%, ENDP +5.4%, SLTD +3.8%, PBR +3.8%, IGLD +3.4%, ASTI +2.2%, AUY +2%, PAAS +1.7%, GOLD +1.6%, AUQ +1.6%, CSIQ +1.4%, TSEM +1.4%, TSEM +1.4%, CSIQ +1.4%, RIG +1.3%, GG +1.3%, CLNT +1%, ITRN +0.9%

Gapping down: BSPM -8.1%, BHP -4.9%, YELP -2.3%, NBG -2.1%, JASO -2.1%, LVS -1.9%, KITE -1.9%, PHG -1.8%, UN -1.6%, DB -1.5%, VOD -1.5%, BUD -1.4%, BBBY -1.3%, CHK -1.3%, MT -1.3%, HSBC -1.1%, STO -0.9%, LYG -0.9%, AZN -0.8%, CVX -0.8%

(NY Post) Intel and Altera resume buyout talks

Intel and Altera have resumed talks about a potential $13 billion-plus buyout after earlier negotiations between the two Silicon Valley chip giants broke down, The Post has learned.
Intel, the much larger company, is looking to diversify as waning demand for personal computers weighs on its mainstay business.
“You should not be surprised if a deal comes together quickly,” said a source with direct knowledge of the talks, adding a resolution one way or the other was expected within a few weeks.
Neither company commented when contacted Sunday.
Both are big players in the semiconductor industry, but they dominate in different areas. Intel mostly supplies chips for personal computers and server systems. Altera is a specialist in programmable chips that can be customized for use in consumer electronics, autos and other applications.
An earlier round of talks between the two ended in April when Altera reportedly rejected an offer of $54 a share. Its shares were trading around $35 in March before talk of a deal leaked.
Even after negotiations stalled, Altera has been trading at an elevated price, suggesting investors are holding out hope that they will eventually reach a deal. The stock closed Friday at $44.42, up 11 cents.
“This is turning into a soap opera,” said Stacy Rasgon, a senior analyst at Bernstein Research.
He said Intel’s announcement this week that it was teaming with startup eASIC was unlikely to weaken its desire for Altera.
“It is a whole other level of programmability,” he said, referring to eASIC’s focus on chips that accelerate computer speeds.
Meanwhile, Reuters reported recently that Avago Technologies was interested in buying Altera competitor Xilinx, although discussions were still at an early stage.

>>> Endo To Acquire Par Pharmaceutical (private) for $8.05B in cash and stock

To Acquire Par Pharmaceutical (private) for $8.05B in cash and stock 

Endo has entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. The combination will create a leading specialty pharmaceutical company with a generics business that is one of the industry's fastest growing and among the top five as measured by U.S. sales. It is also expected to help drive long-term double-digit revenue growth for Endo. The transaction has been unanimously approved by the Boards of Directors of Endo and Par, and is supported by the management teams of both companies. There are no further shareholder approvals required. The purchase price will consist of approximately 18 million shares ($1.55 billion of value based on the 10-day volume weighted average share price of Endo ending on May 15, 2015) of Endo equity and $6.50 billion cash consideration to Par shareholders. Endo has secured fully committed financing from Deutsche Bank and Barclays to fund the cash consideration. Endo expects to implement a permanent capital structure to finance the transaction prior to the close that would include a combination of cash, debt and an equity offering. Par Pharmaceutical is a privately-held company that was acquired through a take-private transaction by an affiliate of TPG in 2012.

The transaction is expected to be accretive to adjusted diluted earnings per share (EPS) within the first 12 months after transaction close and result in double-digit accretion to adjusted diluted EPS in full year 2016. For 2016, Endo anticipates that EBITDA generated by Par will translate into a transaction multiple of approximately 10 to 11 times pro forma adjusted EBITDA on a post-synergized basis. The transaction is expected to close in the second half of 2015 and is subject to regulatory approval in the U.S. and certain other jurisdictions, as well as other customary closing conditions.

With the addition of Par's product portfolio and R&D pipeline, Endo's already rapidly growing generics business unit is expected to become one of the largest and fastest growing in the industry, with double-digit revenue growth over the long-term and a broad product pipeline. The Par portfolio includes nearly 100 products in multiple dosage forms and delivery systems, including oral solids, oral suspensions, injectables and high barrier-to-entry products. This portfolio is highly profitable with increasing adjusted gross margins. The transaction is also expected to help drive double-digit growth for Endo's overall business, expanding the company's corporate scope, size and future M&A potential.

Par offers a solid pipeline consisting of more than 200 Abbreviated New Drug Applications (ANDAs), 115 of which were filed with the FDA as of December 31, 2014. Approximately 33 percent of the filed ANDAs are potential first-to-file or first-to-market opportunities and 75 percent of the overall development portfolio consists of Paragraph IV and first-to-file programs all of which could provide a period of market exclusivity if approved. It is expected that the Par R&D pipeline could generate approximately 20 to 25 ANDA filings each year in 2015, 2016 and 2017.

(BFW) Hikma Founder Samih Darwazah, 85, Dies

Samih Darwazah is holding a 28.75% stake int he company if bbg is up to date

BN 05/18 09:30 *HIKMA FOUNDER DARWAZAH DIED MAY 15
BN 05/18 09:30 *HIKMA HIK HIKMA FOUNDER SAMIH DARWAZAH PASSES AWAY

Hikma Founder Samih Darwazah, 85, Dies
2015-05-18 09:33:35.124 GMT


By Gaurav Panchal
(Bloomberg) -- Died May 15.
* Statement:Link
* Samih Darwazah owns 5.5% stake in co.: Bloomberg data

Link to Company News:{HIK LN <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the editor responsible for this story:
Gaurav Panchal at +44-20-3525-0511 or
gpanchal2@bloomberg.net

>>> Sika: FINMA Takeover Committee reviews Gates/Cascade appeal against opt-out

Sika: FINMA Takeover Committee reviews Gates/Cascade appeal against opt-out

In response to a request made by William H. Gates III, Melinda French Gates (as trustees of the Bill & Melinda Gates Foundation Trust) and Cascade Investment, L.L.C., the Swiss Takeover Board (TOB) concluded in its decision 598/01 of 1 April 2015 that the opting out clause set out in Article 5 of Sika AG's articles of association does apply to the transaction between Schenker-Winkler Holding AG (SWH) and Compagnie de Saint-Gobain (Saint-Gobain) whereby SWH, Saint-Gobain, or any persons acting in concert with them, are not obliged to present a public takeover offer to the Sika AG shareholders. The appeal lodged by William H. Gates III, Melinda French Gates and Cascade Investment, L.L.C. against this decision is currently being reviewed by the FINMA Takeover Committee.

On 18 May Sika announced the shareholder group of Bill & Melinda Gates Foundation Trust and Cascade Investment has today filed an appeal with the Federal Administrative Court:

The shareholder group of William H. Gates III and Melinda French Gates as trustees of Bill & Melinda Gates Foundation Trust and Cascade Investment has today filed an appeal with the Federal Administrative Court against the decision of FINMA of May 4, 2015 (see press release of May 4, 2015 for more information).

(UBS) FFP : Cautious on PSA Peugeot and hence on FFP

Cautious on PSA Peugeot and hence on FFP

* Downside risks prevail on Peugeot (46% of NAV)
We reiterate our Neutral rating on FFP. Despite the remarkable quality of FFP's portfolio
we see it as fairly valued (listed stakes’ value up 40% year-to-date, UBSe). The value of
the shares of PSA Peugeot have notably gained c70% year-to-date and now account
for 46% of the NAV of FFP. UBS has a Sell rating and a DCF-derived PT of €12 (30%
downside) on PSA Peugeot. We also don't see any upside potential for another c24%
of the portfolio (SEB, Zodiac, DKSH, …all Neutral rated) and therefore have a Neutral
rating of FFP. All in all, we see a 7% downside potential in the NAV per share of FFP in
a twelve month view.

* FFP shares trading at a still wide 44% discount to the spot NAV
Such a discount level is wide in absolute terms but is consistent with the 46% average
discount at which FFP shares have traded over the last 5 years (35-55% range since
2010). The modest liquidity of the shares (20% free float) indeed justifies a relatively
wide discount. Given the lack of upside potential in the NAV in a twelve-month view, a
wider discount could also be justified. FFP shares trade at 40% discount to our 12-
month forward NAV of €122, that implicitly assumes that (1) equity markets will remain
supportive and (2) that FFP will continue to smartly manage its portfolio.

* Portfolio rotation: some new investments are likely
Despite the value appreciation of several stakes, we doubt that FFP will sell much of its
existing assets (good quality, long term view). We believe on the contrary that FFP will
look for some new investments. FFP's loan-to-value has indeed decreased to less than
10%, which is very healthy and supports some re-leveraging. We estimate FFP could
invest up to €160m and keep a loan-to-value ratio below 15%. We expect new
investments either in listed or unlisted assets.

* Valuation: PT upgraded to €73 from €57
We have raised our 12-month forward NAV to €122ps from €114 to reflect the higher
market value of SEB and Lisi. Our PT, raised by 28% to €73, now assumes a discount of
40% (50% previously) to our forward NAV. A narrower discount looks indeed justified
to us given the stronger equity markets and good management of the portfolio.

WSJ : Shell Deal Puts BG Gas Holding at Risk

Shell Deal Puts BG Gas Holding at Risk

Kazakhstan Could Exercise Right to Buy Out Stake in Karachaganak Field

LONDON—Buried deep in BG PLC’s annual report is a little-noticed risk for its $70 billion merger with Royal Dutch Shell PLC: The deal could cost Shell a huge Kazakhstan gas field.

In the event of a change in BG’s ownership, the company said in its 2014 report, the Kazakhstan government may claim it has the right to buy out a BG stake in a natural-gas field called Karachaganak that has been a cash cow. It accounted for about 15% of BG’s total production volume and 9% of its $19 billion in revenue in 2014.

The Kazakh government hasn’t disclosed whether it would seek to take over the field or let the Anglo-Dutch energy company keep it after the tie-up’s expected closure in 2016. But the Central Asian nation has exercised its so-called pre-emption rights over resources in the past.

Kazakhstan’s potential rights are among several regulatory risks to Shell’s takeover of U.K.-based BG, which would vault it far ahead of its competitors in the production and sale of liquefied natural gas. Shell also faces potential objections in China, Australia and Brazil, where it could face competition questions as a dominant player in those markets.

BG executives said Shell was handling regulatory approvals for the deal. Asked whether Shell was concerned about Kazakhstan claiming the field, a Shell spokeswoman said that the deal was “pro-competitive” and that the company was confident it would receive the necessary approvals.


A spokesman for Shell said Chief Executive Ben van Beurden traveled to Kazakhstan last month, but the spokesman declined to provide any details.

Kazakhstan’s Energy Ministry said Shell and BG hadn’t provided any information about the matter. “Therefore currently, the ministry has no update on the transaction and the existing agreements between the companies,” Kazakhstan’s first deputy energy minister, Uzakbai Karabalin, said in a written statement.

Karachaganak, in northwest Kazakhstan, is one of the world’s largest gas-condensate fields, with estimated resources in place of nine billion barrels of condensate and 48 trillion cubic feet of gas.

Only 10% of those resources have been produced from the field and significant development opportunities remain, BG said in the report.

Last year, production from the onshore field net to BG was 85,000 barrels of oil equivalent a day. Condensate is a type of valuable ultralight crude oil that is mostly a gas when it is in the ground, but condenses into a liquid when pumped to the surface.

“Karachaganak has been a good cash cow for BG,” said Brendan Warn, senior oil-and-gas analyst at BMO Capital Markets.

Analysts have valued BG’s 29.25% stake in the Kazakh gas field at roughly $4.4 billion based on an oil price of $80 a barrel. An additional 22 years remain on the concession.


“It’s meaningful, but it’s probably not a deal breaker for Shell,” said Jefferies equities analyst Jason Gammel.

In 2013, Kazakhstan’s government exercised its pre-emption rights at the Kashagan oil field, buying ConocoPhillips’ stake in the project for about $5 billion before selling it on to China’s National Petroleum Corp. Conoco had initially planned to sell its interest in Kashagan to India’s Oil and Natural Gas Corp.

Kazakhstan’s oil and gas company, KazMunaiGas, currently holds the smallest stake in Karachaganak among several partners: 10%, acquired in 2012.